TRAWS PHARMA INC (TRAW:NASDAQ)
$0.601 0.0222 (3.8355%)
Analysed TRAWS PHARMA INC (TRAW:NASDAQ) News Sources
Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights
15-04-2026
yahoo.com
Traws Pharma Inc (TRAW) Q4 2025 Earnings Call Highlights: A Turnaround Year with Significant ...
16-04-2026
yahoo.com
Traws Pharma, Inc. (TRAW) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
20-04-2026
yahoo.com
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections
08-05-2026
yahoo.com
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
27-05-2026
yahoo.com
Traws Pharma Provides Regulatory Update on Influenza Program
12-06-2026
yahoo.com
Traws Pharma Shares Slide After UK Regulator Postpones Influenza Study
15-06-2026
advfn.com
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program
22-06-2026
yahoo.com
Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
14-08-2026
yahoo.com
Traws Pharma shares rise after Q2 loss comes in better than expected
17-08-2026
advfn.com
What is the current price of TRAWS PHARMA INC (TRAW:NASDAQ)?
The current price of TRAWS PHARMA INC (TRAW:NASDAQ) is $0.601.
TRAWS PHARMA INC (TRAW:NASDAQ) absolute price change since previous trading day?
The absolute price change of TRAWS PHARMA INC (TRAW:NASDAQ) since the previous trading day is $0.0222.
TRAWS PHARMA INC (TRAW:NASDAQ) percentage price change since previous trading day?
The percentage price change of TRAWS PHARMA INC (TRAW:NASDAQ) since the previous trading day is 3.8355%.
What is the most recent average sentiment score for TRAWS PHARMA INC (TRAW:NASDAQ)?
The most recent average sentiment score for TRAWS PHARMA INC (TRAW:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for TRAWS PHARMA INC (TRAW:NASDAQ)?
The most recent sentiment for TRAWS PHARMA INC (TRAW:NASDAQ) is .
SEC-8K** Filing Available For TRAWS PHARMA INC (TRAW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.